While the Sky News Daily is on a Christmas break, we’re replaying you among the most memorable episodes we recorded in 2024 – beginning with Ozempic.
Anti-obesity jabs like Ozempic might cut back the danger of coronary heart assaults, strokes or coronary heart failure in overweight folks whatever the quantity of weight they lose whereas on the drug.
Researchers discovered after three years of therapy contributors had a 20% decrease threat of weight problems and its related well being impacts, which at the moment value the NHS greater than £6bn annually.
On the Sky News Daily, Niall Paterson speaks to Sky’s science and medical correspondent Thomas Moore in regards to the implications of decreasing coronary heart illness circumstances for the NHS, and senior lecturer in physiology at Anglia Ruskin University Dr Simon Cork explains how the wonder-drug really works.
